Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).
Share price
Orexo has established a social financing framework
Presentation of Q4 2023 incl. the Full Year Report
Click the link to watch the presentation on February 8.
Extraordinary General Meeting on October 26
Read the protocol from the EGM under Corporate Governance - EGM
Latest CEO Comments
FEBRUARY 8, 2024
"Strong recovery in financial results and FDA initiated the review of OX124"
Read the latest CEO comments from Nikolaj Sørensen